These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

97 related items for PubMed ID: 6682326

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. [Betaxolol versus nifedipine in the treatment of essential hypertension].
    Steiner A, Hany S, Bättig B, Jenni R, Troesch M, Willimann P, Graf A, Leutenegger F, Angehrn V, Beck G.
    Schweiz Rundsch Med Prax; 1988 Oct 11; 77(41):1101-3. PubMed ID: 2907178
    [No Abstract] [Full Text] [Related]

  • 23. [Clinical results with carteolol in patients with arrhythmias].
    Strösser W.
    Arzneimittelforschung; 1983 Oct 11; 33(2a):339-45. PubMed ID: 6682327
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [Nadolol, a long-acting beta-blocker, in the treatment of essential arterial hypertension].
    Semplicini A, Pessina AC, Rossi GP, Tagliafierro R, Lusiani L, Castellani V, Bedogni F, Mazzucato A, Ronsisvalle G.
    Cardiologia; 1982 Sep 11; 27(9):853-64. PubMed ID: 6765448
    [No Abstract] [Full Text] [Related]

  • 33. [Monotherapy of hypertension with a beta-receptor blocker].
    Grund R, Schrey A.
    ZFA (Stuttgart); 1982 Nov 10; 58(31):1733-7. PubMed ID: 7180143
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Clinical evaluation of bevantolol hydrochloride in patients with severe hypertension. The Cooperative Study Group on Bevantolol in Japan.
    Noshiro T, Miura Y, Yoshinaga K, Iimura O, Inagaki Y, Saruta T, Ishii M, Yamazaki N, Arakawa K.
    Int J Clin Pharmacol Ther; 1995 Apr 10; 33(4):240-5. PubMed ID: 7620695
    [Abstract] [Full Text] [Related]

  • 36. [Antihypertensive action of various talinolol dosages after four week's treatment in comparison with placebo].
    Weigmann I, Terhaag B, Wierich W, Herrmann WM.
    Arzneimittelforschung; 1998 Mar 10; 48(3):240-4. PubMed ID: 9553680
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [Antihypertensive effects of timolol and of the combination timolol, amiloride and hydrochlorothiazide].
    Cospite M, Ferrara F, Raimondi F, Lo Presti T, Ballo M, Milio G, Meli F.
    Clin Ter; 1981 Sep 30; 98(6):617-26. PubMed ID: 7026143
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.